Database: EBM Reviews - Cochrane Central Register of Controlled Trials <1st Quarter 2009>
Search Strategy:
1(losartan or cozaar).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (965)
2(telmisartan or micardis).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (199)
3(candesartan or atacand).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (418)
4(eprosartan or teveten).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (84)
5(irbesartan or avapro).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (271)
6(olmesartan or benicar).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (50)
7(valsartan or diovan).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (372)
81 or 2 or 3 or 4 or 5 or 6 or 7 (2139)
9(benazepril or lotensin).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (204)
10(captopril or capoten).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (2017)
11(cilazapril or inhibace).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (226)
12(enalapril or vasotec).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (2150)
13(fosinopril or monopril).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (183)
14(lisinopril or prinivil or zestril).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (720)
15(moexipril or univasc).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (33)
16(quinapril or accupril).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (258)
17(ramipril or altace).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (544)
18(perindopril or aceon or coversyl).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (461)
19(trandolapril or mavik).mp. [mp=title, original title, abstract, mesh headings, heading words, keyword] (193)
2011 or 9 or 17 or 12 or 15 or 14 or 18 or 19 or 10 or 13 or 16 (6213)
218 and 20 (604)
22limit 21 to (clinical trial or comparative study or controlled clinical trial or meta analysis or multicenter study or randomized controlled trial) (422)
23observational.mp. (1660)
24retrospective.mp. (5067)
25exp Cohort Studies/or cohort.mp. (77012)
26exp Case-Control Studies/(5306)
27systematic review.mp. (200)
2827 or 25 or 24 or 26 or 23 (82556)
2928 and 21 (101)
3022 or 29 (424)
31from 30 keep 1–424 (424)

From: Appendix B, Search strategies

Cover of Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers
Drug Class Review: Direct Renin Inhibitors, Angiotensin Converting Enzyme Inhibitors, and Angiotensin II Receptor Blockers: Final Report [Internet].
Norris S, Weinstein J, Peterson K, et al.
Portland (OR): Oregon Health & Science University; 2010 Jan.
Copyright © 2009, Oregon Health & Science University, Portland, Oregon.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.